1887

Journal of Medical Microbiology logo

Volume 56, Issue 5

Evolution of antibody response and fungal antigens in the serum of a patient infected with Free

Abstract

The presence of fungal antibodies and antigens in the serum of a patient diagnosed in 1996 with acute zonal occult outer retinopathy caused by infection was examined. Antibodies against increased until 1999–2000 when antifungal treatment was initiated. The antibodies were detected by ELISA and immunofluorescence analysis using . These antibodies were not immunoreactive against several species tested. Positive immunofluorescence was obtained with IgM, but not IgA, IgG or IgE. Moreover, the IgM response disappeared several months after treatment with antifungal compounds, despite the fact that antigens were present in the blood. Finally, a sensitive test was developed to assay for the presence of antigens in serum based on the immunodetection of fungal antigens transferred to a nitrocellulose membrane and incubated with rabbit antibodies raised against . According to this method, the infection diminished with antifungal treatment.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): AZOOR, acute zonal occult outer retinopathy
SGM
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.47042-0
2007-05-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jmm/56/5/571.html?itemId=/content/journal/jmm/10.1099/jmm.0.47042-0&mimeType=html&fmt=ahah

References

  1. Al-Hedaithy S. S. 2003; The yeast species causing fungemia at a university hospital in Riyadh, Saudi Arabia, during a 10-year period. Mycoses 46:293–298
     [Google Scholar]
  2. Almirante B., Rodriguez D., Cuenca-Estrella M., Almela M., Sanchez F., Ayats J., Alonso-Tarres C., Rodriguez-Tudela J. L., Pahissa A. 2006; Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections: case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003. J Clin Microbiol 44:1681–1685 [CrossRef]
     [Google Scholar]
  3. Altamura M., Casale D., Pepe M., Tafaro A. 2001; Immune responses to fungal infections and therapeutic implications. Curr Drug Targets Immune Endocr Metabol Disord 1:189–197 [CrossRef]
     [Google Scholar]
  4. Andrighetto C., Psomas E., Tzanetakis N., Suzzi G., Lombardi A. 2000; Randomly amplified polymorphic DNA (RAPD) PCR for the identification of yeasts isolated from dairy products. Lett Appl Microbiol 30:5–9 [CrossRef]
     [Google Scholar]
  5. Badauy C. M., Barbachan J. J., Rados P. V., Sant'ana Filho M., Chies J. A. 2005; Relationship between Candida infection and immune cellular response in inflammatory hyperplasia. Oral Microbiol Immunol 20:89–92 [CrossRef]
     [Google Scholar]
  6. Brandt M. E., Harrison L. H., Pass M., Sofair A. N., Huie S., Li R. K., Morrison C. J., Warnock D. W., Hajjeh R. A. 2000; Candida dubliniensis fungemia: the first four cases in North America. Emerg Infect Dis 6:46–49 [CrossRef]
     [Google Scholar]
  7. Bretagne S., Costa J. M. 2005; Towards a molecular diagnosis of invasive aspergillosis and disseminated candidosis. FEMS Immunol Med Microbiol 45:361–368 [CrossRef]
     [Google Scholar]
  8. Canteros G. E., Davel G. O., Vivot W. 1994; Causal agents of onychomycosis. Rev Argent Microbiol 26:65–71 (in Spanish)
    [Google Scholar]
  9. Carrasco L., Ramos M., Galisteo R., Pisa D., Fresno M., Gonzalez M. E. 2005; Isolation of Candida famata from a patient with acute zonal occult outer retinopathy. J Clin Microbiol 43:635–640 [CrossRef]
     [Google Scholar]
  10. Clemons K. V., Calich V. L., Burger E., Filler S. G., Grazziutti M., Murphy J., Roilides E., Campa A., Dias M. R. other authors 2000; Pathogenesis I: interactions of host cells and fungi. Med Mycol 38 (Suppl. 1):99–111 [CrossRef]
     [Google Scholar]
  11. Coleman D. C., Rinaldi M. G., Haynes K. A., Rex J. H., Summerbell R. C., Anaissie E. J., Li A., Sullivan D. J. 1998; Importance of Candida species other than Candida albicans as opportunistic pathogens. Med Mycol 36 (Suppl. 1):156–165
     [Google Scholar]
  12. d'Ostiani C. F., Del Sero G., Bacci A., Montagnoli C., Spreca A., Mencacci A., Ricciardi-Castagnoli P., Romani L. 2000; Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans . Implications for initiation of T helper cell immunity in vitro and in vivo. J Exp Med 191:1661–1674 [CrossRef]
     [Google Scholar]
  13. Einsele H., Hebart H., Roller G., Loffler J., Rothenhofer I., Muller C. A., Bowden R. A., van Burik J., Engelhard D. other authors 1997; Detection and identification of fungal pathogens in blood by using molecular probes. J Clin Microbiol 35:1353–1360
     [Google Scholar]
  14. Ellepola A. N., Morrison C. J. 2005; Laboratory diagnosis of invasive candidiasis. J Microbiol 43:65–84
     [Google Scholar]
  15. Fanci R., Guidi S., Bonolis M., Bosi A. 2005; Candida krusei fungemia in an unrelated allogeneic hematopoietic stem cell transplant patient successfully treated with caspofungin. Bone Marrow Transplant 35:1215–1216 [CrossRef]
     [Google Scholar]
  16. Fernandez-Arenas E., Molero G., Nombela C., Diez-Orejas R., Gil C. 2004; Contribution of the antibodies response induced by a low virulent Candida albicans strain in protection against systemic candidiasis. Proteomics 4:1204–1215 [CrossRef]
     [Google Scholar]
  17. Garcia-Gonzalez A., Ochoa J. L. 1999; Anti-inflammatory activity of Debaryomyces hansenii Cu,Zn-SOD. Arch Med Res 30:69–73 [CrossRef]
     [Google Scholar]
  18. Gardini F., Suzzi G., Lombardi A., Galgano F., Crudele M. A., Andrighetto C., Schirone M., Tofalo R. 2001; A survey of yeasts in traditional sausages of southern Italy. FEMS Yeast Res 1:161–167 [CrossRef]
     [Google Scholar]
  19. Gil M. 1997; Conceptos básicos sobre la interacción del sistema inmune y los hongos causales de micosis sistémicas. IATREIA 10:171–176
     [Google Scholar]
  20. Ishibashi K., Yoshida M., Nakabayashi I., Shinohara H., Miura N. N., Adachi Y., Ohno N. 2005; Role of anti- β -glucan antibody in host defense against fungi. FEMS Immunol Med Microbiol 44:99–109 [CrossRef]
     [Google Scholar]
  21. Khan Z. U., Mustafa A. S. 2001; Detection of Candida species by polymerase chain reaction (PCR) in blood samples of experimentally infected mice and patients with suspected candidemia. Microbiol Res 156:95–102 [CrossRef]
     [Google Scholar]
  22. Krcmery V., Barnes A. J. 2002; Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect 50:243–260 [CrossRef]
     [Google Scholar]
  23. Krcmery V., Kunova A. 2000; Candida famata fungemia in a cancer patient: case report. J Chemother 12:189–190 [CrossRef]
     [Google Scholar]
  24. Li Y. L., Leaw S. N., Chen J. H., Chang H. C., Chang T. C. 2003; Rapid identification of yeasts commonly found in positive blood cultures by amplification of the internal transcribed spacer regions 1 and 2. Eur J Clin Microbiol Infect Dis 22:693–696 [CrossRef]
     [Google Scholar]
  25. Lopez-Ribot J. L., Casanova M., Murgui A., Martinez J. P. 2004; Antibody response to Candida albicans cell wall antigens. FEMS Immunol Med Microbiol 41:187–196 [CrossRef]
     [Google Scholar]
  26. Matthews R., Burnie J. 1998; The epidemiology and pathogenesis of candidiasis: application in prevention and treatment. Bull Inst Pasteur 96:249–256 [CrossRef]
     [Google Scholar]
  27. Mencacci A., Cenci E., Del Sero G., d'Ostiani C. F., Montagnoli C., Bacci A., Bistoni F., Romani L. 1999; Innate and adaptive immunity to Candida albicans : a new view of an old paradigm. Rev Iberoam Micol 16:4–7
     [Google Scholar]
  28. Mitsutake K., Miyazaki T., Tashiro T., Yamamoto Y., Kakeya H., Otsubo T., Kawamura S., Hossain M. A., Noda T. other authors 1996; Enolase antigen, mannan antigen, Cand-Tec antigen, and β -glucan in patients with candidemia. J Clin Microbiol 34:1918–1921
     [Google Scholar]
  29. Nishikawa A., Sugita T., Shinoda T. 1999; Rapid identification of Debaryomyces hansenii / Candida famata by polymerase chain reaction. Med Mycol 37:101–104 [CrossRef]
     [Google Scholar]
  30. Pazos C., Ponton J., Del Palacio A. 2005; Contribution of (1→3)- β -d-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan. J Clin Microbiol 43:299–305 [CrossRef]
     [Google Scholar]
  31. Peres-Bota D., Rodriguez-Villalobos H., Dimopoulos G., Melot C., Vincent J. L. 2004; Potential risk factors for infection with Candida spp. in critically ill patients. Clin Microbiol Infect 10:550–555 [CrossRef]
     [Google Scholar]
  32. Pfaller M. A. 1996; Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission. Clin Infect Dis 22 (Suppl. 2):S89–S94 [CrossRef]
     [Google Scholar]
  33. Pfaller M. A., Diekema D. J., Messer S. A., Boyken L., Hollis R. J., Jones R. N. 2003; In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood. J Clin Microbiol 41:78–83 [CrossRef]
     [Google Scholar]
  34. Pontón J. 2006; El diagnóstico microbiológico independiente de cultivo en la candidiasis invasora. Importanciae los marcadores fúngicos. Rev Iberoam Micol 23:20–25 [CrossRef]
     [Google Scholar]
  35. Prinsloo B., Weldhagen G. F., Blaine R. W. 2003; Candida famata central nervous system infection. S Afr Med J 93:601–602
     [Google Scholar]
  36. Pryce T. M., Kay I. D., Palladino S., Heath C. H. 2003; Real-time automated polymerase chain reaction (PCR) to detect Candida albicans and Aspergillus fumigatus DNA in whole blood from high-risk patients. Diagn Microbiol Infect Dis 47:487–496 [CrossRef]
     [Google Scholar]
  37. Quindos G., Moragues M. D., Ponton J. 2004; Is there a role for antibody testing in the diagnosis of invasive candidiasis?. Rev Iberoam Micol 21:10–14
     [Google Scholar]
  38. Rao N. A., Nerenberg A. V., Forster D. J. 1991; Torulopsis candida ( Candida famata ) endophthalmitis simulating Propionibacterium acnes syndrome. Arch Ophthalmol 109:1718–1721 [CrossRef]
     [Google Scholar]
  39. Reboli A. C. 1993; Diagnosis of invasive candidiasis by a dot immunobinding assay for Candida antigen detection. J Clin Microbiol 31:518–523
     [Google Scholar]
  40. Rozell B., Ljungdahl P. O., Martinez P. 2006; Host–pathogen interactions and the pathological consequences of acute systemic Candida albicans infections in mice. Curr Drug Targets 7:483–494 [CrossRef]
     [Google Scholar]
  41. Ruhnke M. 2006; Epidemiology of Candida albicans infections and role of non- Candida albicans yeasts. Curr Drug Targets 7:495–504 [CrossRef]
     [Google Scholar]
  42. Shoham S., Levitz S. M. 2005; The immune response to fungal infections. Br J Haematol 129:569–582 [CrossRef]
     [Google Scholar]
  43. Simitsopoulou M., Roilides E. 2005; Evaluation of immunotherapy in invasive candidiasis: antifungal activity and cytokine expression assays. Methods Mol Med 118:161–179
     [Google Scholar]
  44. Sims C. R., Ostrosky-Zeichner L., Rex J. H. 2005; Invasive candidiasis in immunocompromised hospitalized patients. Arch Med Res 36:660–671 [CrossRef]
     [Google Scholar]
  45. St-Germain G., Laverdiere M. 1986; Torulopsis candida , a new opportunistic pathogen. J Clin Microbiol 24:884–885
     [Google Scholar]
  46. Tortorano A. M., Kibbler C., Peman J., Bernhardt H., Klingspor L., Grillot R. 2006; Candidaemia in Europe: epidemiology and resistance. Int J Antimicrob Agents 27:359–366 [CrossRef]
     [Google Scholar]
  47. van Deventer A. J. M., Goessens W. H. F., van Belkum H. J. A., van Vliet H. J. A., van Etten E. W. M., Verbrugh H. A. 1995; Improved detection of Candida albicans by PCR in blood of neutropenic mice with systemic candidiasis. J Clin Microbiol 33:625–628
     [Google Scholar]
  48. Veldman B. A., Verweij P. E., Blijlevens N. M. 2006; Successful treatment of liposomal amphotericin B refractory Candida glabrata fungaemia in a patient undergoing a stem cell transplantation. Neth J Med 64:127–129
     [Google Scholar]
  49. Villar C. C., Kashleva H., Mitchell A. P., Dongari-Bagtzoglou A. 2005; Invasive phenotype of Candida albicans affects the host proinflammatory response to infection. Infect Immun 73:4588–4595 [CrossRef]
     [Google Scholar]
  50. Wagner D., Sander A., Bertz H., Finke J., Kern W. V. 2005; Breakthrough invasive infection due to Debaryomyces hansenii (teleomorph Candida famata ) and Scopulariopsis brevicaulis in a stem cell transplant patient receiving liposomal amphotericin B and caspofungin for suspected aspergillosis. Infection 33:397–400 [CrossRef]
     [Google Scholar]
  51. Witkin S. S., Yu I. R., Ledger W. J. 1983; Inhibition of Candida albicans -induced lymphocyte proliferation by lymphocytes and sera from women with recurrent vaginitis. Am J Obstet Gynecol 147:809–811
     [Google Scholar]
  52. Wright R., Basson M., D'Ari L., Rine J. 1988; Increased amounts of HMG-CoA reductase induce “Karmellae”: a proliferation of stacked membrane pairs surrounding the yeast nucleus. J Cell Biol 107:101–114 [CrossRef]
     [Google Scholar]
  53. Yamamoto Y., Osanai S., Fujiuchi S., Yamazaki K., Nakano H., Ohsaki Y., Kikuchi K. 2002; Extrinsic allergic alveolitis induced by the yeast Debaryomyces hansenii . Eur Respir J 20:1351–1353 [CrossRef]
     [Google Scholar]
  54. Yang C. W., Barkham T. M., Chan F. Y., Wang Y. 2003; Prevalence of Candida species, including Candida dubliniensis , in Singapore. J Clin Microbiol 41:472–474 [CrossRef]
     [Google Scholar]
  55. Yeo S. F., Wong B. 2002; Current status of nonculture methods for diagnosis of invasive fungal infections. Clin Microbiol Rev 15:465–484 [CrossRef]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.47042-0
Loading
Evolution of antibody response and fungal antigens in the serum of a patient infected with Candida famata
J. Med. Microbiol. 56, 571 (2007); https://doi.org/10.1099/jmm.0.47042-0
/content/journal/jmm/10.1099/jmm.0.47042-0
/content/journal/jmm/10.1099/jmm.0.47042-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error